1-17 of 17
Massimo Porta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Self-management Education by Group Care Reduces Cardiovascular Risk in Patients With Type 2 Diabetes: Analysis of the ROMEO Clinical Trial

Open Access
Jacopo Sicuro, Lorena Charrier, Paola Berchialla, Franco Cavallo, Stefano Merlo, Aurora Mazzeo, Massimo Porta, Marina Trento, for the ROMEO Investigators
Journal: Diabetes Care
Diabetes Care 2014;37(9):e192–e193
https://doi.org/10.2337/dc14-1054
Published: 07 August 2014
View articletitled, Self-management Education by Group Care Reduces Cardiovascular Risk in Patients With Type 2 Diabetes: Analysis of the ROMEO Clinical Trial
Open the PDF for Self-management Education by Group Care Reduces Cardiovascular Risk in Patients With Type 2 Diabetes: Analysis of the ROMEO Clinical Trial in another window
Journal Articles

No Sign of Proliferative Retinopathy in 15 Patients With Permanent Neonatal Diabetes With a Median Diabetes Duration of 24 Years

Open Access
Dario Iafusco, Silvana Salardi, Giovanni Chiari, Sonia Toni, Ivana Rabbone, Roberta Pesavento, Bruno Pasquino, Antonella de Benedictis, Giulio Maltoni, Carlo Colombo, Lucia Russo, Ornella Massa, Maurizio Sudano, Francesco Cadario, Massimo Porta, Fabrizio Barbetti, the Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED)
Journal: Diabetes Care
Diabetes Care 2014;37(8):e181–e182
https://doi.org/10.2337/dc14-0471
Published: 12 July 2014
View articletitled, No Sign of Proliferative Retinopathy in 15 Patients With Permanent Neonatal Diabetes With a Median Diabetes Duration of 24 Years
Open the PDF for No Sign of Proliferative Retinopathy in 15 Patients With Permanent Neonatal Diabetes With a Median Diabetes Duration of 24 Years in another window
Journal Articles

Estimating the Delay Between Onset and Diagnosis of Type 2 Diabetes From the Time Course of Retinopathy Prevalence

Open Access
Massimo Porta, Giulia Curletto, Dario Cipullo, Roberta Rigault de la Longrais, Marina Trento, Pietro Passera, Anna Viola Taulaigo, Sabrina Di Miceli, Antonella Cenci, Paola Dalmasso, Franco Cavallo
Journal: Diabetes Care
Diabetes Care 2014;37(6):1668–1674
https://doi.org/10.2337/dc13-2101
Published: 10 May 2014
View articletitled, Estimating the Delay Between Onset and Diagnosis of Type 2 Diabetes From the Time Course of Retinopathy Prevalence
Open the PDF for Estimating the Delay Between Onset and Diagnosis of Type 2 Diabetes From the Time Course of Retinopathy Prevalence in another window
Journal Articles

Association of Autoimmunity to Autonomic Nervous Structures With Nerve Function in Patients With Type 1 Diabetes: A 16-Year Prospective Study

Open Access
Maria M. Zanone, Alessandro Raviolo, Eleonora Coppo, Marina Trento, Martina Trevisan, Franco Cavallo, Enrica Favaro, Pietro Passera, Massimo Porta, Giovanni Camussi
Journal: Diabetes Care
Diabetes Care 2014;37(4):1108–1115
https://doi.org/10.2337/dc13-2274
Published: 08 March 2014
View articletitled, Association of Autoimmunity to Autonomic Nervous Structures With Nerve Function in Patients With Type 1 Diabetes: A 16-Year Prospective Study
Open the PDF for Association of Autoimmunity to Autonomic Nervous Structures With Nerve Function in Patients With Type 1 Diabetes: A 16-Year Prospective Study in another window
Journal Articles

Comment on: Beverly et al. Do Older Adults Aged 60–75 Years Benefit From Diabetes Behavioral Interventions? Diabetes Care 2013;36:1501–1506

Open Access
Marina Trento, MEDSCI, MBA, Pietro Passera, MD, Franco Cavallo, MD, Massimo Porta, MD, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(8):e125
https://doi.org/10.2337/dc13-0241
Published: 11 July 2013
View articletitled, Comment on: Beverly et al. Do Older Adults Aged 60–75 Years Benefit From Diabetes Behavioral Interventions? Diabetes Care 2013;36:1501–1506
Open the PDF for Comment on: Beverly et al. Do Older Adults Aged 60–75 Years Benefit From Diabetes Behavioral Interventions? Diabetes Care 2013;36:1501–1506 in another window
Journal Articles

Infant and Toddler Type 1 Diabetes: Complications after 20 years’ duration

Open Access
Silvana Salardi, MD, Massimo Porta, MD, Giulio Maltoni, MD, Flavia Rubbi, MD, Silvia Rovere, MD, Franco Cerutti, MD, Dario Iafusco, MD, Stefano Tumini, MD, Vittoria Cauvin, MD, the Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology (ISPED)
Journal: Diabetes Care
Diabetes Care 2012;35(4):829–833
https://doi.org/10.2337/dc11-1489
Published: 13 March 2012
View articletitled, Infant and Toddler Type 1 Diabetes: Complications after 20 years’ duration
Open the PDF for Infant and Toddler Type 1 Diabetes: Complications after 20 years’ duration in another window
Journal Articles

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

Open Access
Joanne W.Y. Yau, MBBS, Sophie L. Rogers, MEPID, Ryo Kawasaki, PHD, Ecosse L. Lamoureux, PHD, Jonathan W. Kowalski, PHARMD, Toke Bek, PHD, Shih-Jen Chen, PHD, Jacqueline M. Dekker, PHD, Astrid Fletcher, PHD, Jakob Grauslund, MD, Steven Haffner, PHD, Richard F. Hamman, PHD, M. Kamran Ikram, PHD, Takamasa Kayama, MD, Barbara E.K. Klein, PHD, Ronald Klein, PHD, Sannapaneni Krishnaiah, MD, Korapat Mayurasakorn, MD, Joseph P. O’Hare, MD, Trevor J. Orchard, MD, Massimo Porta, PHD, Mohan Rema, MD, Monique S. Roy, MD, Tarun Sharma, MD, Jonathan Shaw, PHD, Hugh Taylor, AC, James M. Tielsch, PHD, Rohit Varma, MD, Jie Jin Wang, PHD, Ningli Wang, MD, Sheila West, PHD, Liang Xu, PHD, Miho Yasuda, PHD, Xinzhi Zhang, PHD, Paul Mitchell, PHD, Tien Y. Wong, PHD, for the Meta-Analysis for Eye Disease (META-EYE) Study Group
Journal: Diabetes Care
Diabetes Care 2012;35(3):556–564
https://doi.org/10.2337/dc11-1909
Published: 10 February 2012
View articletitled, Global Prevalence and Major Risk Factors of Diabetic Retinopathy
Open the PDF for Global Prevalence and Major Risk Factors of Diabetic Retinopathy in another window
Includes: Supplementary data
Journal Articles

A Study of Patients’ Perceptions of Diabetes Care Delivery and Diabetes: Propositional analysis in people with type 1 and 2 diabetes managed by group or usual care

Open Access
Marzia Raballo, BEDSCI, Martina Trevisan, BEDSCI, Anna Franca Trinetta, BNUTRSCI, Lorena Charrier, MD, Franco Cavallo, MD, Massimo Porta, MD, Marina Trento, MEDSCI
Journal: Diabetes Care
Diabetes Care 2012;35(2):242–247
https://doi.org/10.2337/dc11-1495
Published: 16 January 2012
View articletitled, A Study of Patients’ Perceptions of Diabetes Care Delivery and Diabetes: Propositional analysis in people with type 1 and 2 diabetes managed by group or usual care
Open the PDF for A Study of Patients’ Perceptions of Diabetes Care Delivery and Diabetes: Propositional analysis in people with type 1 and 2 diabetes managed by group or usual care in another window
Journal Articles

Rethink Organization to iMprove Education and Outcomes (ROMEO): A multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes

Open Access
Marina Trento, MEDSCI, BPSYCHOL, MBA, Silvia Gamba, MD, Luigi Gentile, MD, Giorgio Grassi, MD, Valerio Miselli, MD, Gabriel Morone, MD, Pietro Passera, MD, Laura Tonutti, MD, Marco Tomalino, MD, Piervincenzo Bondonio, MBA, Franco Cavallo, MD, Massimo Porta, MD, PHD, for the ROMEO Investigators
Journal: Diabetes Care
Diabetes Care 2010;33(4):745–747
https://doi.org/10.2337/dc09-2024
Published: 26 January 2010
View articletitled, Rethink Organization to iMprove Education and Outcomes (ROMEO): A multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes
Open the PDF for Rethink Organization to iMprove Education and Outcomes (ROMEO): A multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes in another window
Includes: Supplementary data
Journal Articles

Quality of Life, Coping Ability, and Metabolic Control in Patients With Type 1 Diabetes Managed By Group Care and a Carbohydrate Counting Program

Open Access
Marina Trento, MES, MBA, Enrica Borgo, Claudia Kucich, MD, Pietro Passera, MD, Anna Trinetta, BS, Lorena Charrier, MD, Franco Cavallo, MD, Massimo Porta, MD, PHD
Journal: Diabetes Care
Diabetes Care 2009;32(11):e134
https://doi.org/10.2337/dc09-0903
Published: 01 November 2009
View articletitled, Quality of Life, Coping Ability, and Metabolic Control in Patients With Type 1 Diabetes Managed By Group Care and a Carbohydrate Counting Program
Open the PDF for Quality of Life, Coping Ability, and Metabolic Control in Patients With Type 1 Diabetes Managed By Group Care and a Carbohydrate Counting Program in another window
Journal Articles

Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in Europe: The EURODIAB Prospective Complications Study (PCS)

Free
Sabita S. Soedamah-Muthu, PHD, Nish Chaturvedi, MD, Daniel R. Witte, PHD, Lynda K. Stevens, MSC, Massimo Porta, MD, John H. Fuller, FRCP, for the EURODIAB Prospective Complications Study Group
Journal: Diabetes Care
Diabetes Care 2008;31(7):1360–1366
https://doi.org/10.2337/dc08-0107
Published: 01 July 2008
View articletitled, Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in Europe: The EURODIAB Prospective Complications Study (PCS)
Open the PDF for Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in Europe: The EURODIAB Prospective Complications Study (PCS) in another window
Journal Articles

Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes: Response to Nathan et al.

Free
Massimo Porta, MD, PHD, Marina Trento, BED SCI
Journal: Diabetes Care
Diabetes Care 2007;30(1):193
https://doi.org/10.2337/dc06-1828
Published: 01 January 2007
View articletitled, Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes: Response to Nathan et al.
Open the PDF for Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes: Response to Nathan et al. in another window
Journal Articles

Diabetic Retinopathy Is Associated With Mortality and Cardiovascular Disease Incidence : The EURODIAB Prospective Complications Study

Free
Manon V. van Hecke, MD, Jacqueline M. Dekker, PHD, Coen D.A. Stehouwer, MD, PHD, Bettine C.P. Polak, MD, PHD, John H. Fuller, FRCP, Anne Katrin Sjolie, DSCI, Athanasios Kofinis, MD, Raoul Rottiers, MD, Massimo Porta, MD, PHD, Nish Chaturvedi, MRCP
Journal: Diabetes Care
Diabetes Care 2005;28(6):1383–1389
https://doi.org/10.2337/diacare.28.6.1383
Published: 01 June 2005
View articletitled, Diabetic Retinopathy Is Associated With Mortality and Cardiovascular Disease Incidence : The EURODIAB Prospective Complications Study
Open the PDF for Diabetic Retinopathy Is Associated With Mortality and Cardiovascular Disease Incidence : The EURODIAB Prospective Complications Study in another window
Journal Articles

A 5-Year Randomized Controlled Study of Learning, Problem Solving Ability, and Quality of Life Modifications in People With Type 2 Diabetes Managed by Group Care

Free
Marina Trento, BED SCI, Pietro Passera, MD, Enrica Borgo, MD, Marco Tomalino, MD, Marina Bajardi, B PSYCH, Franco Cavallo, MD, Massimo Porta, MD, PHD
Journal: Diabetes Care
Diabetes Care 2004;27(3):670–675
https://doi.org/10.2337/diacare.27.3.670
Published: 01 March 2004
View articletitled, A 5-Year Randomized Controlled Study of Learning, Problem Solving Ability, and Quality of Life Modifications in People With Type 2 Diabetes Managed by Group Care
Open the PDF for A 5-Year Randomized Controlled Study of Learning, Problem Solving Ability, and Quality of Life Modifications in People With Type 2 Diabetes Managed by Group Care in another window
Journal Articles

Group Visits Improve Metabolic Control in Type 2 Diabetes: A 2-year follow-up

Free
Marina Trento, B. ED. SCI., Pietro Passera, MD, Marco Tomalino, MD, Marina Bajardi, B. PSYCH., Fulvio Pomero, MD, Attilio Allione, MD, Piero Vaccari, B. PSYCH., Gian Michele Molinatti, MD, Massimo Porta, MD, PHD
Journal: Diabetes Care
Diabetes Care 2001;24(6):995–1000
https://doi.org/10.2337/diacare.24.6.995
Published: 01 June 2001
View articletitled, Group Visits Improve Metabolic Control in Type 2 Diabetes: A 2-year follow-up
Open the PDF for Group Visits Improve Metabolic Control in Type 2 Diabetes: A 2-year follow-up in another window
Journal Articles

Markers of Insulin Resistance Are Strong Risk Factors for Retinopathy Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study

Free
Nish Chaturvedi, MRCP, Anne-Katrin Sjoelie, MD, Massimo Porta, MD, Steven J. Aldington, FBIPP, John H. Fuller, FRCP, Marco Songini, MD, Eva M. Kohner, FRCOPHTH, The EURODIAB Prospective Complications Study Group
Journal: Diabetes Care
Diabetes Care 2001;24(2):284–289
https://doi.org/10.2337/diacare.24.2.284
Published: 01 February 2001
View articletitled, Markers of Insulin Resistance Are Strong Risk Factors for Retinopathy Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study
Open the PDF for Markers of Insulin Resistance Are Strong Risk Factors for Retinopathy Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study in another window
Journal Articles

von Willebrand Factor and Endothelial Abnormalities in Diabetic Microangiopathy

Free
Massimo Porta, MD, PhD, Macro La Selva, PhD, Pia A Molinatti, MD
Journal: Diabetes Care
Diabetes Care 1991;14(2):167–172
https://doi.org/10.2337/diacare.14.2.167
Published: 01 February 1991
View articletitled, von Willebrand Factor and Endothelial Abnormalities in Diabetic Microangiopathy
Open the PDF for von Willebrand Factor and Endothelial Abnormalities in Diabetic Microangiopathy in another window